This week Hill-Rom (NYSE: HRC) is featuring the Progressa® bed system, the next generation of intensive care unit (ICU) bed systems, at the American Organization of Nurse Executives (AONE) annual meeting in Orlando, Fla. The Progressa bed system is a therapeutic system designed to treat and prevent complications of immobility. It features a state-of-the-art design that supports treatment goals and was engineered to help address patient migration via its StayInPlace™ technology.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/66137-hill-rom-new-progressa-bed-system
An iconic symbol of Easter, the PEEPS® brand has been the Easter basket staple for just over 60 years. With more than 1.5 billion PEEPS® consumed during Easter alone, it’s no wonder PEEPS® have remained the #1 non-chocolate candy at Easter for more than 20 years. From making colorful additions to baked goods, to decorative accents for craft and art projects, to fun little surprises hidden inside Easter eggs or simply savoring the sweet treat on its own, PEEPS® are sure to bring a smile to kids of all ages.
To view Multimedia News Release, go to http://www.multivu.com/mnr/65392-just-born-easter-basket-favorite-peeps-offers-variety-for-everyone
Vioxx Settlement
This is an important announcement for consumers about the prescription drug Vioxx. Vioxx was a drug commonly used to treat pain and inflammation in adults with arthritis.
A settlement was reached with the manufacturer of Vioxx and will provide refunds to anyone who paid for the medication. Consumers are eligible to get $50 or more. Personal injury claims related to this drug are not included in this settlement.
The deadline to file a claim is approaching – claims must be filed by May 6, 2014.
Details are available at http://www.VioxxSettlement.com or by calling 1-866-439-6932.
MilkSplash™, the zero–calorie milk flavoring, is the perfect solution for parents who want their kids to drink more milk and make healthier beverage choices this summer. A gentle squeeze and simple stir can turn nutritious white milk into a delicious treat kids will love.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/7141851-milksplash-from-s-and-d-beverage-innovations-makes-drinking-milk-awesome
http://yourinnerpower.com.au/ - David Wilson an alcohol & cocaine addict, came to Your Inner Power 6 months ago to help him get rid of his addiction. Jackie Durnin used EFT Tapping technique to treat his addiction. Visit us to know more!
Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report, “A Decade of Innovation in Rare Diseases,” to document the significant progress made in the last 10 years in understanding a broad range of rare diseases and translating this knowledge into groundbreaking therapies for a variety of patient populations.
The report illustrates that more than 230 new medicines to treat rare or “orphan” diseases were approved by the U.S. Food and Drug Administration (FDA) in the last decade, and there are currently more than 450 orphan drugs in development.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7350554-phrma-report-innovation-rare-diseases/
The spring season is finally upon us and the candy connoisseurs at Just Born Quality Confections continue to whip up new PEEPS® flavors and products to fit every PEEPSONALITY®! With more than a dozen different product varieties available in numerous colors, shapes and flavors, the versatile marshmallow treat is sure to show up in Easter baskets, artwork and recipes and as always, the star of dioramas. Regardless of how they are used, the nostalgic favorite is sure to bring smiles to fans of all ages.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7404453-peeps-easter-marshmallow/
Alimera Sciences, Inc. (NASDAQ: ALIM) (Alimera), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that many retina specialists throughout the U.S. are now using ILUVIEN® (fluocinolone acetonide intravitreal implant) 0.19 mg to treat patients with diabetic macular edema (DME). The first injections of ILUVIEN in the U.S. were captured during a live web event attended by more than 250 eye care professionals. ILUVIEN is the first multiyear eye implant designed to deliver a continuous, submicrogram daily dose of steroid to the retina for 36 months with one injection. ILUVIEN is indicated for the treatment of DME in patients who have been previously treated with a course of corticosteroids and did not have a clinically significant rise in intraocular pressure (IOP).
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7496251-iluvien-dme/
Calling all cheesecake fanatics! Fiber One is introducing the perfect treat to satisfy cheesecake cravings any time with new Fiber One Cheesecake Bars in Salted Caramel and Strawberry. In honor of the new, guilt-free treat, Fiber One is turning National Cheesecake Day – July 30 – into a month-long cheesecake celebration. The brand kicked off the celebration with a pop-up Cheesecake Café sampling event at Grand Central Station, in New York City on National Cheesecake Day. The cheesecake celebration will continue throughout August 2015, when Fiber One will host its own Cheesecake Appreciation Month Sweepstakes* and a partnership with Hungry Girl to give tips on guilt-free ways to indulge in the dessert.
“We are excited to introduce a guilt-free option inspired by a classic American dessert,” said Maria Lopez, associate marketing manager. “Fiber One Cheesecake Bars have cheesecake taste and texture that fulfill cheesecake cravings. This new offering is definitely worth celebrating throughout August and beyond.”
With five grams of fiber and 150 calories per individually packaged bar, Fiber One Cheesecake Bars are the perfect guilt-free dessert with the added benefit of fiber. The irresistible layers of graham cracker-y goodness and creamy cheesecake allow you to indulge in a sweet treat without fighting your instincts to fill your cheesecake cravings
To view the multimedia release visit:
http://www.multivu.com/players/English/7551251-fiber-one-cheesecake-bars/
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Invuity, Inc. (NASDAQ:IVTY), an advanced medical technology company, announced today the launch of its Hidden ScarTM Surgery program designed to certify surgeons and establish Centers of Excellence at major cancer centers and hospitals across the country. This innovative program will train surgeons on advanced minimally invasive and minimal access surgical approaches that deliver optimal clinical and aesthetic outcomes for patients. As part of the company’s broader women’s health initiative, Invuity is hosting a Hidden Scar Breast Cancer Surgery training course in advance of the American College of Surgeons (ACS) Clinical Congress.
Invuity aims to transform the surgical treatment of breast cancer with this advanced surgical approach for nipple sparing mastectomies and lumpectomies (breast conserving surgery). Hidden Scar Breast Cancer Surgery expands surgical options for patients, offering superior cosmetic outcomes that can improve their psychological and emotional recovery and enhance quality of life after surgery.1
With growing demand for less invasive alternatives to breast cancer surgery, surgeons need to operate through smaller incisions with limited fields of vision. Invuity’s illumination technology allows surgeons to access and visualize the entire breast cavity through discrete incision locations, enabling surgeons to safely and effectively treat breast cancer while preserving the natural shape of the breast and thereby minimizing and hiding the scars.
To view the multimedia release go to:
http://www.multivu.com/players/English/7644051-invuity-hidden-scar-breast-cancer-surgery-program/
Spotted: Nick Offerman and his dad Ric fishing in a handmade canoe on a serene and quiet lake, communicating as only fathers and sons do.
Of the experience, Offerman said, “Working with my Dad (aka my hero) was a sincere honor and a treat - especially since all we had to do was go fishing. And if people have enjoyed my stoic expressions, then I expect they’re about to have their hats fly off when they lay eyes on the face of the august edifice from whence I sprung.”
Grab your dad, pour yourselves a glass of Lagavulin and enjoy responsibly.
To view the multimedia release go to:
http://www.multivu.com/players/English/7848951-my-tales-of-whisky-fathers-day/
